Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb randomized double-blind placebo-controlled study of oral CMS203 tablets in men with erectile dysfunction
CTR20253583Phase 2Active
- Sponsor
- 山东鲁抗医药股份有限公司、济南美鲁威生物科技有限公司、上海中拓医药科技有限公司/ 山东鲁抗医药股份有限公司
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CMS203 in erectile dysfunction (ED), sponsored by 山东鲁抗医药股份有限公司、济南美鲁威生物科技有限公司、上海中拓医药科技有限公司/ 山东鲁抗医药股份有限公司. Started Mar 2026; status: active.
02
Drugs
CMS203
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on CTR20253583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253583.